First non-antipsychotic medication for Alzheimer’s agitation gets FDA approval
FDA Approves First Non-Antipsychotic Treatment for Alzheimer’s Agitation The U.S. Food and Drug Administration has approved a groundbreaking non-antipsychotic medication to treat agitation in individuals with Alzheimer’s disease. Known as Overity, the drug was initially sanctioned by the FDA in 2022 for treating adults suffering from major depressive disorder. Its recent approval expands its use […]
DEI triggered a recruitment crisis in the US, risky anti-ICE agitation, and other insights
Military Impact: DEI Created US Draft Dilemma A “racist ideology of diversity, equity, and inclusion” has reportedly led to a “draft crisis” within the U.S. military, displacing many white men. This viewpoint is presented by Mike Gallagher and Kevin Wallsten in a piece for the Wall Street Journal. Under President Joe Biden’s leadership, military leadership […]